Cats
with small tumors located on the lower jaw (mandible) that are treated with surgery have a better chance of surviving for one year; however, most will still eventually succumb to the disease.
Of the 82 treated patients
with small tumors, 96 percent (79 of 82) have had no recurrence more than three years after treatment, and 80 percent (28 of 35) of those with mid-size tumors also have had no recurrence.
Not exact matches
The targeted radiotherapy shrank
tumors for 71 % of patients who had already failed standard chemotherapy, but these results came from a
small trial that started
with 30 patients and then added another 20 after positive data started rolling in.
«Particularly in such patients
with underlying CKD, our modeling results support the integration of renal
tumor anatomic features at cross-sectional imaging into decision making for treatment of
small renal masses and may be used to provide a patient - centered framework for selection of optimal candidates for ablative therapy,» Kang said.
Led by Stella K. Kang, a radiologist
with the Department of Radiology at the New York School of Medicine, the study was designed to compare the effectiveness of a treatment algorithm for
small renal
tumors incorporating the nephrometry score, a renal
tumor anatomy scoring system developed by urologists,
with the current standard of uniformly recommended partial nephrectomy in patients
with mild - to - moderate chronic kidney disease (CKD).
But x-rays are not good at spotting tiny
tumors, partly because of a lack of contrast and partly because the calcifications associated
with tumors are much
smaller than benign deposits and therefore easy to overlook.
Small populations of adult stem cells
with somewhat limited developmental potential are responsible for the body's ability to heal injuries and replace worn out cells and tissues, and evidence is growing that rare cancer stem cells are responsible for the uncontrolled growth of some malignant
tumors, including glioblastoma.
Northwestern Medicine scientists have identified a
small RNA molecule called miR - 182 that can suppress cancer - causing genes in mice
with glioblastoma mulitforme (GBM), a deadly and incurable type of brain
tumor.
When injected
with cancer cells, animals housed there developed
tumors 80 %
smaller than those in control mice, or no
tumors at all.
Our job now is to figure out how to make immunotherapy effective against those
tumors with small numbers of mutations.
«Even a
small amount of infection
with oHSV appears to be enough to trigger an immune response to the
tumor.»
A
tumor treated
with verteporfin (right) is much
smaller and much of the structure of the mouse's eye is visible.
Although surgery that is confined to removing just a
small tumor (loco - regional treatment) is generally considered to be low risk, we have previously demonstrated that the proportion of patients who develop postoperative complications strongly increases
with age and increasing numbers of other diseases or conditions that they may have.
In contrast, the LDL - DHA rats had
smaller, pale
tumors with poor blood supply.
A global analysis of metabolites and
small molecules in urine samples from patients
with adrenal cancer has identified four biochemicals that, when measured together, can distinguish malignant from benign adrenal
tumors, according to study results presented at the 2015 Annual Clinical Congress of the American College of Surgeons.
At worst we would end up
with a few little pebble
tumors,
small balls of abnormal cells that had exhausted their ability to grow, no more life - threatening than a mole or a
small cyst.
«We wanted to utilize platelets» intrinsic tendencies to accumulate at wounds and to interact
with circulating
tumor cells, for targeted delivery of immune checkpoint inhibitors» said Gu, «Interestingly, we found the antibody can be promoted to release from activated platelets in the surgical site, due to generation of
small platelet - derived microparticles upon the platelet activation.
The approach was most successful in making a difference in samples from the two patients in which the
smaller - sized
tumor DNA was not readily apparent, which may represent patients
with low
tumor burden and previously difficult to detect circulating
tumor DNA.
The study showed that mice implanted
with breast cancer cells lacking the protein developed
small, self - contained
tumors consisting of cells that didn't leave the
tumor.
But in at least one case, a
small tumor merged
with the cells lining the faux blood vessel.
After ten days of PDT treatment, the
tumors were found to be far
smaller than comparative groups not treated
with light.
This is where
small molecule therapeutics could be developed to interfere
with the signals and suppress
tumor growth.
«We showed
with this technique that we can detect very tiny
tumors of just a few hundred cells,» Lu said, adding that the study pushed imaging boundaries, revealing
smaller cancers than can be detected
with current clinical imaging modalities.
In patients likely to have surgery, close, active monitoring of
small renal
tumors confined to the kidneys is associated
with low rates of
tumor growth or death, according to a study by a researcher at the Icahn School of Medicine at Mount Sinai published in the September issue of The Journal of Urology.
He was part of a team that recognized that only about 10 % of patients
with NSCLC responded to the
small molecule erlotinib — those whose
tumors harbored mutations in the gene encoding EGFR.
Results showed that
tumor cells containing the protein carried anywhere from 10 to 17 times fewer breast stem cells, and
tumors grown from the injected cells were about three times
smaller than those in mice who had received
tumor cells
with depleted levels of HOXA5.
Using a very sensitive DNA analysis technique that can also be employed when only very
small amounts of DNA from old tissue are available, the researchers could compare the two current cell lines
with the
tumor from which the cell line was established.
In fact, the mice that received the complete nanomedicine package had
smaller tumors and longer lifespans than their counterparts injected
with saline, nanoparticles without the drug, the drug alone, and nanoparticles
with the drug but without the targeting aptamers.
Among lung cancer patients; suicide SMR was higher in males (SMR = 8.8), Asians (SMR = 13.7), widowed patients (SMR = 11.6), older patients (70 - 75 years; SMR = 12), patients
with undifferentiated
tumors (SMR 8.6) or
small cell lung carcinoma (SCLC) histology (SMR = 11.2), patients presenting
with metastatic disease (SMR = 13.9) and in patients who refused to receive surgical treatment (SMR = 13).
Dr Jeremy Thomas, a consultant pathologist at the Western General Hospital, Edinburgh, UK, told the European Breast Cancer Conference that although the majority of women
with DCIS received the correct surgery for their disease, large numbers of women were undergoing mastectomy for DCIS either as a result of failed breast conservation surgery or for
tumors that turned out to be
smaller than 20 mm in diameter and therefore should normally have had a lumpectomy rather than a mastectomy.
The total number of women who had mastectomies, including those for whom mastectomy was the first course of action as well as those who had failed breast conservation, was 2,479; of these, 510 (21 %) had mastectomies for
tumors smaller than 20 mm in diameter, which would normally have been better treated
with a lumpectomy.
Pre-malignant aneuploid cells grew more slowly and formed
smaller tumors than comparable cells
with normal chromosome number.»
The study also points to an increased incidence of
tumors compared
with those not operated on, but there the risks remained very
small.
VIC - 008 is a fusion protein combining an immune - activating protein from the tuberculosis bacteria
with a
small antibody fragment targeting mesothelin, a protein expressed in several types of
tumor — including mesothelioma, pancreatic and ovarian cancer.
• A patient's undifferentiated
small bowel sarcoma was found to contain a KIT gene deletion, resulting in a revised diagnosis of GIST (gastrointestinal stromal
tumor) that was successfully treated
with imatinib.
A
tumor treated
with verteporfin (right) is
smaller and much of the structure of the mouse's eye is visible.
In fact, large human liver cancer
tumors on comparatively
small mice started regressing about 20 days after treatment, and were eradicated by day 41
with the help of one of the targeted receptors.
Adding the monoclonal antibody drug trastuzumab — already used to treat certain breast cancers — to the chemotherapy regimen of women
with a rare form of uterine cancer lengthens the amount of time their
tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a
small phase II trial of the regimen, testing its safety and value.
Can
tumors be detected when they are two to three orders of magnitude
smaller than those currently detected
with in vivo imaging modalities?
Finding cancer early can improve a patient's chances for survival, but
small tumors can be difficult to see
with scanning techniques such as magnetic resonance...
But as fewer and fewer women were diagnosed
with large breast
tumors, pre-op chemo began to be used in patients
with smaller cancers, too, in the hope that it would extend survival.
He performed the first of these inoculations in 1891, on a patient named Zola, an Italian immigrant
with a
tumor «the size of a
small hen's egg» in his right tonsil, who likely had only weeks to live.
In 12 mice, MRI was able to detect the one relatively large
tumor, 17 out of 18
small tumors that were
smaller than a millimeter, and 13 out of 16 milk ducts that were distended
with carcinoma in situ, including some
tumors less than 300 microns in width, about one - third of a millimeter.
Rather, each
tumor contains a
small subset of cells
with stem cell - like capacities that are responsible for initiating and sustaining
tumor growth, while the bulk of the
tumor cells lacks this ability.
Among married patients studied, almost 47 percent had the
smallest, earliest - stage
tumors compared
with 43... -LSB-...]
When they blocked IKK2 activity in the mice
with lung cancer, the mice had
smaller tumors and lived longer, suggesting that the enzyme is necessary for NF - KB to stimulate
tumor growth.
The researchers found that non-Hispanic white women were more likely to have
smaller tumors, and more likely to have the less - aggressive HR + / HER2 - subtype of breast cancer, compared
with African - American women, who were more likely to have large
tumors, more likely to have the aggressive triple - negative breast cancer, and 40 to 70 percent more likely to be diagnosed at stage 4 of all subtypes of breast cancer.
The
tumors formed in mice co-treated
with chidamide and decitabine were significantly
smaller than those that formed in untreated animals or those treated
with the single agents, starting from 15 days of treatment (Figure 4C, left panel), as visualized by 18F - fluorodeoxyglucose
small - animal positron emission tomography — computed tomography at 21 days of treatment (Figure 4C, right panel).
«We also identified a way to inhibit the SOX9 stabilization by treating the
tumors with small molecular drugs, which made them less resistant to chemotherapy again.»
Mice injected
with a strain of the Zika virus lived longer and were measured to have
smaller tumors than the control group, which was injected
with saltwater.